Journal
ACTA PHARMACEUTICA SINICA B
Volume 6, Issue 5, Pages 384-392Publisher
INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2016.07.014
Keywords
Isoniazid; Metabolism; Hepatotoxicity; Anti-tuberculosis; N-Acetyltransferase 2; Amidase
Categories
Funding
- NIDDK NIH HHS [R01 DK090305] Funding Source: Medline
- NIGMS NIH HHS [R01 GM087376, R01 GM118367] Funding Source: Medline
Ask authors/readers for more resources
Isoniazid (INH) is highly effective for the management of tuberculosis. However, it can cause liver injury and even liver failure. INH metabolism has been thought to be associated with INH-induced liver injury. This review summarized the metabolic pathways of INH and discussed their associations with INH-induced liver injury. (C) 2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available